We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

72 hedge funds and large institutions have $143M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

13% more capital invested

Capital invested by funds: $127M → $143M (+$16.7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 77 → 72 (-5)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
72
Holders Change
-5
Holders Change %
-6.49%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
30
Reduced
17
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAM
Senzar Asset Management
New York
+$4.73M
2
DA
DSC Advisors
Illinois
+$3.05M
3
BFA
BlackRock Fund Advisors
California
+$2.78M
4
OM
Opaleye Management
Massachusetts
+$1.61M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$3.72M
2
AC
Ascend Capital
California
-$1.93M
3
UBS AM
UBS AM
Illinois
-$1.83M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.64M
5
EI
EAM Investors
California
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$827K – – –
UBS AM
27
UBS AM
Illinois
$799K -$1.83M -244,299 -71%
Baird Financial Group
28
Baird Financial Group
Wisconsin
$682K +$517K +69,134 +461%
BIM
29
BlackRock Investment Management
Delaware
$675K +$1.67K +224 +0.3%
TCIM
30
TIAA CREF Investment Management
New York
$618K – – –
Vanguard Group
31
Vanguard Group
Pennsylvania
$527K +$20K +2,675 +4%
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$518K -$1.64M -219,663 -77%
DCM
33
DAFNA Capital Management
California
$493K +$454K +60,770 New
Federated Hermes
34
Federated Hermes
Pennsylvania
$487K – – –
Deutsche Bank
35
Deutsche Bank
Germany
$470K -$102K -13,637 -19%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$441K +$247K +33,103 +156%
LOAMU
37
Lombard Odier Asset Management (USA)
New York
$437K +$16.1K +2,155 +4%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$340K +$5.6K +749 +2%
AC
39
Ascend Capital
California
$337K -$1.93M -258,389 -86%
AA
40
ALPS Advisors
Colorado
$326K -$51.1K -6,836 -15%
QSS
41
Quantitative Systematic Strategies
Florida
$302K +$275K +36,788 New
Geode Capital Management
42
Geode Capital Management
Massachusetts
$273K +$11.1K +1,483 +5%
TA
43
Teachers Advisors
New York
$266K – – –
Charles Schwab
44
Charles Schwab
California
$263K – – –
Wells Fargo
45
Wells Fargo
California
$263K +$130K +17,441 +116%
ARTA
46
A.R.T. Advisors
New York
$252K +$233K +31,140 New
ProShare Advisors
47
ProShare Advisors
Maryland
$226K +$208K +27,868 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$184K +$24.3K +3,250 +17%
Morgan Stanley
49
Morgan Stanley
New York
$177K -$2.8K -375 -2%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$167K – – –
1
2
3 4

FOMX Hedge Fund Activity: Q4 2015 in Review

72 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q4 2015, worth a combined $143M — up 13% from $127M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of FOMX and 8 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 30 added.

The largest buyer was Senzar Asset Management, adding an estimated $4.73M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.72M sold.

  • 72 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q4 2015, down from 77 in Q3 2015.
  • Funds reported $143M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q4 2015, up 13% quarter-over-quarter.
  • 8 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q4 2015 and 12 closed out, a net change of -4 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q4 2015 was Senzar Asset Management, an estimated $4.73M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q4 2015 was PFM Health Sciences, an estimated $3.72M sold.

Based on aggregated 13F filings for Q4 2015.